Ångström AI
YC S24San Francisco, US · Founded 2024 · 5 employees · 1 known investors
Ångström AI develops AI-powered physics simulations for pharmaceutical drug discovery, computing molecular properties like solubility, lipophilicity, and crystal structure stability to replace traditional lab experiments. The platform uses machine learning interatomic potentials and free energy calculations to accelerate and derisk solid form development for pharma companies.
AI & Machine LearningBiotechDeep TechHealthtechAI-powered Drug DiscoveryArtificial IntelligenceDrug discoveryAIin /angstrom-ai/@Angstrom_ai
Founders & leadership· Y Combinator alumni (S24)
Laurence Midgleyin𝕏Founder